億晶光電(600537.SH):滁州10GW N型TOPCon電池項目廠房已建設完成
格隆匯1月8日丨億晶光電(600537.SH)在投資者互動平台表示,公司滁州10GW N型TOPCon電池項目廠房已建設完成,首批5GW設備已到場安裝並完成調試,後5GW設備到場安裝完成進度30%-40%,合計調試完成可投產產能約6GW,當前項目進度有所滯後,主要原因系市場對於大尺寸、矩形電池片需求的增速加快,公司原定設備需要做部分改造,以匹配硅片尺寸的變化。為節約公司設備改造成本,公司主動叫停設備廠商發貨。目前滁州TOPCon電池項目A級率達到97%+,轉化效率可達到26.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.